The Canadian COVID‑19 Funded Research Database

Back to main page

Displaying 361 through 370 of 424 results (Download Results)

Show results per page

Investigating access to and outcomes from supervised drug consumption services in British Columbia before and during the COVID‑19 pandemic

Kerr, Thomas H | British Columbia Centre on Substance Use | Operating Grant | $249,065

CIHR British Columbia 2021

COVID-19 Variant Supplement – Shutting down emerging Coronaviruses in humans now and in the future

Barr, Stephen D | Western University | Operating Grant | $50,000

CIHR Ontario 2021

Brain Injury Pandemic Preparedness: Optimizing Community Strategies

Bottari, Carolina | CIUSSS du Centre-Sud-de-l'Île-de-Montréal | Project Grant | $218,025

CIHR Quebec 2021

COVID-19 Variant Supplement – Neutralizing Antibodies as SARS-CoV-2 Therapeutics

Rini, James M | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

Pathogenesis and immune escape potential of SARS-CoV-2 variants of concern.

Flamand, Louis | CHU de Québec | Operating Grant | $252,900

CIHR Quebec 2021

COVID-19 Variant Supplement – CovidFree@Home: Development and validation of a multivariable prediction model of deterioration in patients diagnosed with COVID‑19 who are managing at home

Gershon, Andrea S | Sunnybrook Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

Addressing socioeconomic and racial/ethnic inequities in COVID‑19 vaccine hesitancy among parents and adolescents

Zinszer, Kate A | Université de Montréal | Operating Grant | $478,685

CIHR Quebec 2021

COVID-19 Variant Supplement – Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID‑19 disease

Kaufmann, Daniel E | Centre hospitalier de l'Université de Montréal | Operating Grant | $50,000

CIHR Quebec 2021

Assessing Immunogenicity of Covid-19 Vaccines in Survivors of Hematological and Solid Cancers

Grant, Michael D | Memorial University of Newfoundland | Operating Grant | $379,900

CIHR Newfoundland and Labrador 2021

COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

James, Michael N | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback